ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 996,64
0,49%
Dow Jones
38 789,18
0,29%
DAX
18 175,21
1,01%
Brent Oil
83,375
0,30%
Bitcoin
63 415,30
-0,91%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Gain Therapeutics Inc (GANX)

  7. Gain Therapeutics Inc (GANX) Actualités

GANX Gain Therapeutics Inc

2,85
-0,11 (-3,72%)
Dernière mise à jour : 20:37:26
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Gain Therapeutics Inc GANX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,11 -3,72% 2,85 20:37:26
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,99 2,82 3,025 2,96
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
24/4/202415:25GLOBEGain Therapeutics Announces Positive Results from the Single..
08/4/202415:25GLOBEGain Therapeutics Bolsters Management Team with the..
01/4/202415:25GLOBEGain Therapeutics Strengthens Management Team and Appoints..
26/3/202413:00GLOBEGain Therapeutics Reports Financial Results for Year End..
15/3/202419:30GLOBEGain Therapeutics to Present at Public Ventures Discovery..
05/3/202414:00GLOBEGain Therapeutics Presents Data at the AD/PD™ 2024..
27/2/202420:00GLOBEGain Therapeutics Announces the Initiation of the Multiple..
22/2/202413:00EDGAR2Form 8-K - Current report
14/2/202418:29GLOBEGain Therapeutics Announces 2024 R&D Update on Parkinson’s..
06/2/202415:56GLOBEUPDATE - Gain Therapeutics’ GT-02287 Completely Restores..
06/2/202414:00GLOBEGain Therapeutics’ GT-02287 Completely Restores Motor..
31/1/202423:26EDGAR2Form 8-K - Current report
31/1/202414:00GLOBEGain Therapeutics’ CEO Matthias Alder Issues Letter to..
02/1/202422:09EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/1/202414:00GLOBEGain Therapeutics Announces Acceptance of Late-Breaking..
02/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
19/12/202322:52EDGAR2Form S-1 - General form for registration of securities under..
01/12/202314:00GLOBEGain Therapeutics Announces Preclinical Data Showing..
29/11/202314:00GLOBEGain Therapeutics to Participate in AI Driven Drug Discovery..
24/11/202319:01GLOBEGain Therapeutics Announces Closing of $10.1 Million Public..
24/11/202312:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/11/202323:27EDGAR2Form 8-K - Current report
21/11/202314:54GLOBEGain Therapeutics Announces Pricing of $9.4 Million Public..
20/11/202322:22EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/11/202322:03GLOBEGain Therapeutics Announces Proposed Public Offering
17/11/202322:27EDGAR2Form 8-K - Current report
14/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202322:02EDGAR2Form 8-K - Current report
14/11/202313:00GLOBEGain Therapeutics Announces Third Quarter 2023 Financial..
04/10/202313:00GLOBEGain Therapeutics Announces Dosing of First Two Subjects in..
25/9/202322:05GLOBEGain Therapeutics to Participate at Cantor Fitzgerald Global..
20/9/202322:05GLOBEGain Therapeutics to Present at the Cambridge Healthtech..
12/9/202315:25GLOBEGain Therapeutics Receives Approval to Commence Phase 1..
10/8/202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:02EDGAR2Form 8-K - Current report
10/8/202313:00GLOBEGain Therapeutics Announces Second Quarter 2023 Financial..
07/8/202313:00GLOBEGain Therapeutics Announces Acceptance of Late Breaking..
31/7/202314:00GLOBEGain Therapeutics to Participate in the 2023 BTIG Virtual..
01/6/202314:00GLOBEGain Therapeutics to Present at the Jefferies Healthcare..
12/5/202314:00GLOBEGain Therapeutics Reports First Quarter 2023 Financial..

Dernières Valeurs Consultées

NASDAQ
GANX
Gain Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés